glp 1 agonist black box warning GLP-1 receptor agonists—the class of drugs behind Ozempic, Wegovy, and Mounjaro—may do more than regulate blood sugar and weight. ⁠ ⁠ In an analysis of more than 6,800 colon cancer patients across glp 1 agonist black box

"Lilly's phase 2 retatrutide results published in The New England Journal of Medicine show the investigational molecule achieved up to 17.5% mean weight reduction at 24 weeks in adults with obesity and overweight"

But, theres a lack of research involving human subjects on this matter

Bodhale DW, Nisar A, Afzulpurkar N

GHK-Cu shows meaningful evidence for hair benefits it extends the anagen (active growth) phase of hair follicles, increases dermal papilla cell activity, and may inhibit the follicle miniaturization signals that contribute to thinning hair

The science behind the link Well, RA isnt just joint pain its an autoimmune disease linked with inflammation, metabolic issues (obesity, insulin resistance), and cardiovascular risk

Marjot, E